Giuseppe Matarese

44PUBLICATIONS
184CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical virologyAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (44)

|Aug 11, 2026
FCGR3A Polymorphism Controls B-Cell Repopulation Kinetics in People With Multiple Sclerosis Treated With Ocrelizumab.

|Jul 28, 2026
CCL2: A Pro-Inflammatory Driver and Candidate Diagnostic Biomarker in Colorectal Cancer Patients.

|Dec 17, 2025
Treg Susceptibility to Cladribine-Induced Depletion Correlates With Therapy Response in Patients With Multiple Sclerosis.

Ilenia Cammarata, Giorgia Sartori, Tiziano Giacomelli

|Jun 12, 2025
Plasma microRNA Signature as Predictive Marker of Clinical Response to Therapy During Multiple Sclerosis.

Fortunata Carbone, Alessandra Colamatteo, Teresa Micillo

|May 28, 2025
MicroRNA-142-3p shuttling in extracellular vesicles marks regulatory T cell dysfunction in multiple sclerosis.

|Apr 04, 2025
A disease-specific convergence of host and Epstein-Barr virus genetics in multiple sclerosis.

Rosella Mechelli, Renato Umeton, Gianmarco Bellucci

Pageof 8

Frequent Collaborators

6 joint publications

Mario Galgani

6 joint publications

Paola de Candia

5 joint publications

Alessandra Colamatteo

4 joint publications

Antonio Porcellini